Polyomavirus hominis 1, better known as BK virus (BKV), infects up to 90% of the general
population. However, significant clinical manifestations are rare and limited to individuals …

Background. Polyomavirus-associated nephropathy (PVAN) is an important cause of kidney
graft loss but there is no consensus on its management. This study aimed to systematically …

Our purposes were to determine the incidence of BK viruria, viremia or nephropathy with
tacrolimus (FK506) versus cyclosporine (CyA) and whether intensive monitoring and …

Polyomavirus-associated nephropathy (PVAN) is a significant cause of allograft loss. The
diagnosis requires allograft biopsy, but the impact of the histological features on diagnosis …

Nephropathy from BK virus (BKV) infection is an evolving challenge in kidney transplant
recipients. It is the consequence of modern potent immunosuppression aimed at reducing …

BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients.
Background BK virus nephritis (BKVN) has emerged as an important cause of renal …

Persisting polyomavirus replication is now widely recognized as a (re‐) emerging cause of
renal allograft dysfunction. Up to 5% of renal allograft recipients can be affected about 40 …

Background. In recent years an increasing number of cases with polyomavirus (PV)‐
nephropathy after renal transplantation were reported from several transplant centres. New …

BK viremia and nephritis are increasing problems in renal transplant recipients. The exact
cause of the increasing prevalence of this condition remains poorly understood. Increasing …

Up to 10% of renal transplant recipients can develop polyomavirus nephropathy (PVN) in
the allograft, leading to premature graft failure. Recent studies have shown that early …